Bone Marrow Stimulation for Osteochondral Lesions of the Talus: Are Clinical Outcomes Maintained 10 Years Later?

Abstract

Background:

Arthroscopic bone marrow stimulation (BMS) is considered the first-line treatment for osteochondral lesions of the talus (OLTs). However, the long-term stability of the clinical success of BMS remains unclear.

Purpose:

To investigate the long-term clinical outcomes among patients who underwent BMS for OLT and to identify prognostic factors for the need for revision surgery.

Study Design:

Case series; Level of evidence, 4.

Methods:

A retrospective analysis was performed on 202 ankles (189 patients) that were treated with BMS for OLT and had a minimum follow-up of 10 years. The visual analog scale for pain, American Orthopaedic Foot & Ankle Society ankle-hindfoot score, and the Foot and Ankle Outcome Score (FAOS) were assessed by repeated measures analysis of variance. Prognostic factors associated with revision surgery were evaluated with Cox proportional hazard regression models and log-rank tests.

Results:

The mean lesion size was 105.32 mm² (range, 19.75-322.79); 42 ankles (20.8%) had large lesions (≥150 mm²). The mean visual analog scale for pain improved from 7.11 ± 1.73 (mean ± SD) preoperatively to 1.44 ± 1.52, 1.46 ± 1.57, and 1.99 ± 1.67 at 1, 3 to 6, and ≥10 years, respectively, after BMS (P < .001). The mean ankle-hindfoot score also improved, from 58.22 ± 13.57 preoperatively to 86.88 ± 10.61, 86.17 ± 10.23, and 82.76 ± 11.65 at 1, 3 to 6, and ≥10 years after BMS (P < .001). The FAOS at the final follow-up was 82.97 ± 13.95 for pain, 81.81 ± 14.64 for symptoms, 83.49 ± 11.04 for activities of daily living, 79.34 ± 11.61 for sports, and 78.71 ± 12.42 for quality of life. Twelve ankles underwent revision surgery after a mean 53.5 months. Significant prognostic factors associated with revision surgery were the size of the lesion (preoperative magnetic resonance imaging measurement ≥150 mm²; P = .014) and obesity (body mass index ≥25; P = .009).

Conclusion:

BMS for OLT yields satisfactory clinical outcomes at a mean follow-up of 13.9 years. The success of the surgery may depend on the lesion size and body mass index of the patient.

Keywords

ankle osteochondral lesion arthroscopic bone marrow stimulation long-term outcomes

Get full access to this article

View all access options for this article.

References

Becher

Driessen

Hess

Longo

Maffulli

Thermann

Microfracture for chondral defects of the talus: maintenance of early results at midterm follow-up. Knee Surg Sports Traumatol Arthrosc. 2010;18:656-663.

Buckwalter

JA.

Articular cartilage injuries. Clin Orthop Relat Res. 2002;402:21-37.

Burdett

RG.

Forces predicted at the ankle during running. Med Sci Sports Exerc. 1982;14:308-316.

Choi

Youn

Park

Lee

JW.

Osteochondral lesions of the talus: are there any differences between osteochondral and chondral types?

Am J Sports Med. 2013;41:504-510.

Choi

Lee

KB.

Arthroscopic microfracture for osteochondral lesions of the talus: functional outcomes at a mean of 6.7 years in 165 consecutive ankles. Am J Sports Med. 2020;48:153-158.

Choi

Kim

Lee

JW.

Prognostic significance of the containment and location of osteochondral lesions of the talus: independent adverse outcomes associated with uncontained lesions of the talar shoulder. Am J Sports Med. 2013;41:126-133.

Choi

Kim

Lee

JW.

Osteochondral lesion of the talus: could age be an indication for arthroscopic treatment?

Am J Sports Med. 2012;40:419-424.

Choi

Park

Kim

Lee

JW.

Osteochondral lesion of the talus: is there a critical defect size for poor outcome?

Am J Sports Med. 2009;37:1974-1980.

Chuckpaiwong

Berkson

Theodore

GH.

Microfracture for osteochondral lesions of the ankle: outcome analysis and outcome predictors of 105 cases. Arthroscopy. 2008;24:106-112.

10.

Clanton

Johnson

Matheny

LM.

Outcomes following microfracture in grade 3 and 4 articular cartilage lesions of the ankle. Foot Ankle Int. 2014;35:764-770.

11.

D’Ambrosi

Maccario

Serra

Ursino

Usuelli

FG.

Relationship between symptomatic osteochondral lesions of the talus and quality of life, body mass index, age, size and anatomic location. Foot Ankle Surg. 2018;24:365-372.

12.

Dahmen

Lambers

KTA

Reilingh

van Bergen

CJA

Stufkens

SAS

Kerkhoffs

No superior treatment for primary osteochondral defects of the talus. Knee Surg Sports Traumatol Arthrosc. 2018;26:2142-2157.

13.

Dekker

Tainter

Easley

Adams

SB.

Treatment of osteochondral lesions of the talus: a critical analysis review. JBJS Rev. 2017;5(3):01874474-201703000-00001.

14.

Dougherty

Howard

Cost-effectiveness in orthopedics: providing essential information to both physicians and health care policy makers for appropriate allocation of medical resources. Sports Med Arthrosc Rev. 2013;21:166-168.

15.

Erickson

Fillingham

Hellman

Parekh

Gross

CE.

Surgical management of large talar osteochondral defects using autologous chondrocyte implantation. Foot Ankle Surg. 2018;24:131-136.

16.

Furukawa

Eyre

Koide

Glimcher

MJ.

Biochemical studies on repair cartilage resurfacing experimental defects in the rabbit knee. J Bone Joint Surg Am. 1980;62:79-89.

17.

Han

Lee

Kang

ES.

Radiographic changes and clinical results of osteochondral defects of the talus with and without subchondral cysts. Foot Ankle Int. 2006;27:1109-1114.

18.

Hannon

Bayer

Murawski

, et al. Debridement, curettage, and bone marrow stimulation: proceedings of the international consensus meeting on cartilage repair of the ankle. Foot Ankle Int. 2018;39:16S-22S.

19.

Imhoff

Paul

Ottinger

, et al. Osteochondral transplantation of the talus: long-term clinical and magnetic resonance imaging evaluation. Am J Sports Med. 2011;39:1487-1493.

20.

Kim

Song

Baek

Hwang

Jeong

BO.

Analysis of the changes in the clinical outcomes according to time after arthroscopic microfracture of osteochondral lesions of the talus. Foot Ankle Int. 2018;40:74-79.

21.

Klammer

Maquieira

Spahn

Vigfusson

Zanetti

Espinosa

Natural history of nonoperatively treated osteochondral lesions of the talus. Foot Ankle Int. 2015;36:24-31.

22.

Kuni

Schmitt

Chloridis

Ludwig

Clinical and MRI results after microfracture of osteochondral lesions of the talus. Arch Orthop Trauma Surg. 2012;132:1765-1771.

23.

Kwak

Kern

Ferkel

Chan

Kasraeian

Applegate

GR.

Autologous chondrocyte implantation of the ankle. Am J Sports Med. 2014;42:2156-2164.

24.

Lee

Bai

Yoon

Jung

Seon

JK.

Second-look arthroscopic findings and clinical outcomes after microfracture for osteochondral lesions of the talus. Am J Sports Med. 2009;37(suppl 1):63S-70S.

25.

Lee

Chung

Kwon

, et al. Transcultural adaptation and testing psychometric properties of the Korean version of the Foot and Ankle Outcome Score (FAOS). Clin Rheumatol. 2013;32:1443-1450.

26.

Lee

Kwon

Choi

Lee

JW.

Comparison of outcomes for osteochondral lesions of the talus with and without chronic lateral ankle instability. Foot Ankle Int. 2015;36:1050-1057.

27.

Lee

Tran

Cooper

Park

Perumal

Clinical outcomes of osteochondral lesions of the tibial plafond following arthroscopic microfracture. Foot Ankle Int. 2019;40:1018-1024.

28.

Minas

Nehrer

Current concepts in the treatment of articular cartilage defects. Orthopedics. 1997;20:525-538.

29.

Polat

Ersen

Erdil

Kizilkurt

Kilicoglu

Asik

Long-term results of microfracture in the treatment of talus osteochondral lesions. Knee Surg Sports Traumatol Arthrosc. 2016;24:1299-1303.

30.

Schmid

Pfirrmann

Hodler

Vienne

Zanetti

Cartilage lesions in the ankle joint: comparison of MR arthrography and CT arthrography. Skeletal Radiol. 2003;32:259-265.

31.

Shapiro

Koide

Glimcher

MJ.

Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1993;75:532-553.

32.

Shimozono

Hurley

Myerson

Kennedy

JG.

Good clinical and functional outcomes at mid-term following autologous osteochondral transplantation for osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc. 2018;26:3055-3062.

33.

Shimozono

Hurley

Yasui

Deyer

Kennedy

JG.

The presence and degree of bone marrow edema influence midterm clinical outcomes after microfracture for osteochondral lesions of the talus. Am J Sports Med. 2018;46:2503-2508.

34.

Stauffer

Chao

Brewster

RC.

Force and motion analysis of the normal, diseased, and prosthetic ankle joint. Clin Orthop Relat Res. 1977;127:189-196.

35.

Tanaka

Takakura

Hayashi

Taniguchi

Kumai

Sugimoto

Low tibial osteotomy for varus-type osteoarthritis of the ankle. J Bone Joint Surg Br. 2006;88:909-913.

36.

Toale

Shimozono

Mulvin

Dahmen

Kerkhoffs

Kennedy

JG.

Midterm outcomes of bone marrow stimulation for primary osteochondral lesions of the talus: a systematic review. Orthop J Sports Med. 2019;7:2325967119879127.

37.

van Bergen

Kox

Maas

Sierevelt

Kerkhoffs

van Dijk

CN.

Arthroscopic treatment of osteochondral defects of the talus: outcomes at eight to twenty years of follow-up. J Bone Joint Surg Am. 2013;95:519-525.

38.

van Dijk

Reilingh

Zengerink

van Bergen

CJ.

Osteochondral defects in the ankle: why painful?

Knee Surg Sports Traumatol Arthrosc. 2010;18:570-580.

39.

Verhagen

Maas

Dijkgraaf

Tol

Krips

van Dijk

CN.

Prospective study on diagnostic strategies in osteochondral lesions of the talus: is MRI superior to helical CT?

J Bone Joint Surg Br. 2005;87:41-46.

40.

Yasui

Hannon

Fraser

, et al. Lesion size measured on MRI does not accurately reflect arthroscopic measurement in talar osteochondral lesions. Orthop J Sports Med. 2019;7:2325967118825261.

41.

Yoshimura

Kanazawa

Takeyama

, et al. Arthroscopic bone marrow stimulation techniques for osteochondral lesions of the talus: prognostic factors for small lesions. Am J Sports Med. 2013;41:528-534.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.30 MB